A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers
Clinical trial NCT03843775 · COMPLETED
Trial details
- NCT number
- NCT03843775
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-14
- Primary completion
- 2023-09-02
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.